There are hundreds of cell types in the human body, each with a specific role spelled out in their DNA. In theory, all it ...
FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked ...
If you ever wondered why the signs that you see on the highway, particularly green, here are some safety-based reasons you ...
Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...
New evidence hints that statins may protect a wider range of people with type 2 diabetes than previously assumed. A major ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...
Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing Phase 2 ZEPHYR and IRIS clinical studies, which are ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback